Ambroxol Modulates Nav1.8, TRPV1, and TRPA1 in Neuropathic P
2026-06-25
The referenced study uncovers the mechanistic actions of ambroxol on key sensory ion channels—Nav1.8, TRPV1, and TRPA1—implicated in neuropathic pain. By delineating species-specific channel inhibition and reversible modulation of human TRPV1 and TRPA1, the research provides a foundation for expanding topical analgesic strategies with minimized systemic side effects.
Spermine in Cellular Metabolism: Protocols & Ion Channel Mod
2026-06-24
Spermine, an endogenous polyamine, empowers advanced research in ion channel regulation and nuclear membrane dynamics. This article delivers stepwise protocols, troubleshooting insights, and translational guidance for leveraging Spermine in cutting-edge cellular metabolism and membrane fusion studies.
3-Aminobenzamide (PARP-IN-1): Precision in Host-Pathogen Res
2026-06-23
Explore the advanced applications of 3-Aminobenzamide (PARP-IN-1) as a potent PARP inhibitor in dissecting host-pathogen interactions. This article reveals unique assay strategies and protocol insights, extending beyond traditional oxidative stress and nephropathy models.
HSP90 Inhibition Destabilizes METTL3 and Suppresses MYC in C
2026-06-23
This study reveals that inhibiting HSP90 with 17-AAG triggers degradation of the m6A methyltransferase METTL3, thereby reducing MYC mRNA methylation and stability in colorectal cancer cells. The findings illuminate a novel HSP90-METTL3-MYC regulatory axis, offering potential therapeutic avenues for colorectal cancer intervention.
TBST (Tris-Buffered Saline and Tween 20): Technical Applicat
2026-06-22
TBST (Tris-Buffered Saline and Tween 20) is a ready-to-use buffer that addresses high background and nonspecific binding in antibody-based immunoassays by functioning as a reliable blocking and washing solution. It is most effective in workflows such as Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry, but should be avoided in protocols incompatible with non-ionic detergents.
Cryo-EM Reveals Structural Diversity of Full-Length αvβ3 Int
2026-06-22
The referenced study provides high-resolution cryo-EM structures of full-length human αvβ3 integrin, uncovering five previously unrecognized intermediate conformations and a novel tetrameric assembly. These findings deepen our understanding of integrin activation mechanisms and offer a framework for rational drug design targeting this key membrane protein.
Intravesical p21 mRNA-LNP Therapy: Advances in Bladder Cance
2026-06-21
This article analyzes a recent open-access study that demonstrates the therapeutic potential of intravesical delivery of p21 mRNA-loaded lipid nanoparticles (LNPs) in bladder cancer. The research introduces a robust method for tumor suppressor restoration, with implications for localized mRNA therapies in oncology.
Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S
2026-06-20
The referenced study introduces an advanced patient-derived gastric cancer assembloid model, integrating matched tumor organoids with autologous stromal cell subpopulations to better replicate the tumor microenvironment. This approach enables more accurate drug response profiling and provides deeper insights into resistance mechanisms, supporting the development of personalized cancer therapies.
(+)-Bicuculline: Technical Guide for GABAA Receptor Antagoni
2026-06-19
(+)-Bicuculline is a classical GABAA receptor antagonist used to dissect inhibitory neurotransmission and modulate synaptic NMDA receptor signaling in neuroscience research. It is unsuitable for diagnostic or clinical applications and requires careful handling for reproducible results. This guide provides actionable parameters and workflow best practices for reliable use.
CCCP and Mitochondrial Morphodynamics: Beyond Uncoupling
2026-06-19
Explore how CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is revolutionizing mitochondrial research, from precise disruption of the proton gradient to advanced applications in live-cell morphodynamics and biomarker development. This article offers a deeper, practical perspective for translational scientists.
RNA Pol II Inhibition Triggers Apoptosis via Degradation, No
2026-06-18
Harper et al. reveal that cell death initiated by RNA Pol II inhibition is an active, regulated apoptotic process independent of global transcriptional shutdown. The study uncovers a novel signaling pathway linking loss of hypophosphorylated RNA Pol IIA to mitochondrial apoptosis, with significant implications for apoptosis research and drug mechanism interpretation.
7-Ethyl-10-hydroxycamptothecin: Applied Workflows in Colon C
2026-06-18
7-Ethyl-10-hydroxycamptothecin delivers dual-action efficacy as a topoisomerase I inhibitor and FUBP1 disruptor in advanced colon cancer research. This guide translates breakthrough findings into practical protocols, troubleshooting tips, and comparative workflow advantages for high-fidelity apoptosis and cell cycle studies.
DiscoveryProbe Natural Product Library Plus: Validated Scree
2026-06-17
The DiscoveryProbe Natural Product Library Plus offers 1,655 quality-validated natural products for high throughput screening in drug discovery. This resource enables rapid identification of cell-permeable bioactive compounds, with proven utility in antiparasitic research and robust support for signal transduction studies.
HNRNPU K181 Lactylation Rewires Serine Metabolism in Cervica
2026-06-17
This study uncovers how lactylation of HNRNPU at lysine 181 promotes cervical cancer growth by stabilizing PHGDH mRNA and reprogramming serine metabolism. The findings identify lactylation as a dynamic post-translational modification that integrates metabolic and transcriptional regulation, highlighting a potential therapeutic target in the metabolic vulnerabilities of cervical cancer.
Dual-Action p38α MAPK Inhibitors Enhance Dephosphorylation D
2026-06-16
The reference study uncovers that certain p38α MAPK inhibitors not only block kinase activity but also promote dephosphorylation by stabilizing a phosphatase-accessible activation loop conformation. These mechanistic insights advance the rational design of more potent and specific anti-inflammatory agents and inform future approaches in cytokine signaling research.
458 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page